Cardiovascular drugs play a crucial role in managing and treating various conditions affecting the heart and blood vessels. These medications are designed to regulate the cardiovascular system, helping to control blood pressure, reduce cholesterol levels, and manage other cardiovascular disorders. Common types of cardiovascular drugs include beta-blockers, which block the effects of adrenaline and lower heart rate; ACE inhibitors, which relax blood vessels and decrease blood pressure; and statins, which effectively lower cholesterol levels. Additionally, antiplatelet drugs, such as aspirin, help prevent blood clot formation. The use of these medications is often tailored to an individual's specific health needs and may involve a combination of drugs to achieve optimal results. It is crucial for healthcare professionals to carefully prescribe and monitor these medications to ensure their effectiveness and minimize potential side effects. Patients prescribed cardiovascular drugs should adhere to their treatment plans, attend regular check-ups, and make lifestyle adjustments to promote overall heart health.
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain